Asparaginase enzyme

This page covers all Asparaginase enzyme drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Asparagine (amino acid substrate).

Targets

Asparagine (amino acid substrate)

Phase 3 pipeline (1)

• E. coli Asparaginase, PEG-L-asparaginase · St. Jude Children's Research Hospital · Oncology
  PEG-L-asparaginase depletes the amino acid asparagine in leukemic cells, which cannot synthesize their own asparagine and thus undergo apoptosis.

Patent intelligence

• asparaginase enzyme patent landscape — aggregated cliff calendar, attackable patents, originator estates